Fortress Biotech Inc (FBIO)
1.72
-0.18
(-9.47%)
USD |
NASDAQ |
Nov 04, 16:00
1.72
0.00 (0.00%)
After-Hours: 16:10
Fortress Biotech Research and Development Expense (TTM): 71.93M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 71.93M |
| March 31, 2024 | 91.40M |
| December 31, 2023 | 106.07M |
| September 30, 2023 | 127.12M |
| June 30, 2023 | 136.67M |
| March 31, 2023 | 137.66M |
| December 31, 2022 | 134.88M |
| September 30, 2022 | 142.81M |
| June 30, 2022 | 140.99M |
| March 31, 2022 | 141.69M |
| December 31, 2021 | 125.12M |
| September 30, 2021 | 100.03M |
| June 30, 2021 | 85.71M |
| March 31, 2021 | 69.15M |
| December 31, 2020 | 64.11M |
| September 30, 2020 | 69.77M |
| June 30, 2020 | 71.28M |
| March 31, 2020 | 72.72M |
| December 31, 2019 | 81.33M |
| September 30, 2019 | 82.76M |
| June 30, 2019 | 87.27M |
| March 31, 2019 | 86.05M |
| December 31, 2018 | 87.38M |
| September 30, 2018 | 76.74M |
| June 30, 2018 | 73.14M |
| Date | Value |
|---|---|
| March 31, 2018 | 69.14M |
| December 31, 2017 | 52.49M |
| September 30, 2017 | 48.65M |
| June 30, 2017 | 40.78M |
| March 31, 2017 | 35.70M |
| December 31, 2016 | 35.12M |
| September 30, 2016 | 30.30M |
| June 30, 2016 | 32.95M |
| March 31, 2016 | 28.50M |
| December 31, 2015 | 29.76M |
| September 30, 2015 | 25.77M |
| June 30, 2015 | 16.42M |
| March 31, 2015 | 14.83M |
| December 31, 2014 | 10.24M |
| September 30, 2014 | 15.02M |
| June 30, 2014 | 18.78M |
| March 31, 2014 | 24.20M |
| December 31, 2013 | 25.68M |
| September 30, 2013 | 24.75M |
| June 30, 2013 | 23.16M |
| March 31, 2013 | 19.89M |
| December 31, 2012 | 18.50M |
| September 30, 2012 | 16.32M |
| June 30, 2012 | 14.30M |
| March 31, 2012 | 11.92M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
64.11M
Minimum
Dec 2020
142.81M
Maximum
Sep 2022
103.71M
Average
100.03M
Median
Sep 2021
Research and Development Expense (TTM) Benchmarks
| Journey Medical Corp | 12.53M |
| Checkpoint Therapeutics Inc | 26.77M |
| Avenue Therapeutics Inc | 5.642M |
| Phathom Pharmaceuticals Inc | 42.46M |
| NovaBay Pharmaceuticals Inc | 0.043M |